AG00IBDB

64485-93-4 | sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

AG00IBDB

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	64485-93-4
Catalog Number	AG00IBDB(AGN-PC-0TCOFT)
Chemical Name	sodium (6R,7R)-3-[(acetyloxy)methyl]-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
EC Number	264-915-9
IUPAC Name	sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
InChI	InChI=1S/C16H17N5O7S2.Na/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8;/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26);/q;+1/p-1/b20-9-;/t10-,14-;/m1./s1
InChI Key	AZZMGZXNTDTSME-JUZDKLSSSA-M
MDL Number	MFCD00079073
Molecular Formula	C16H16N5NaO7S2
Molecular Weight	477.4473
SMILES	O=C([O-])C(N1[C@@]([H])([C@@H](C1=O)NC(/C(C2=CSC(N)=N2)=N/OC)=O)SC3)=C3COC(C)=O.[Na+]
UNII	258J72S7TZ
Synonyms	Benaxima, Biosint, Cefotaxim, Cefotaxime, Cefotaxime Sodium, Cefradil, Cephotaxim, Claforan, Fotexina, HR 756, HR-756, HR756, Kendrick, Klaforan, Primafen, Ru 24756, Ru-24756, Ru24756, Sodium, Cefotaxime, Taporin, CEFOTAXIME SODIUM, 64485-93-4, Sodium cefotaxime, CEFOTAXIME SODIUM SALT, Tolycar, Pretor, (+)-Cefotaxime sodium salt, Cefotax, Cefotaxime (sodium salt), HR 756, Claforan, UNII-258J72S7TZ, Cefotaxim sodium salt, Cefotaxime sodium salt (syn-isomer), MFCD00079073, Ralopar, Tolycor, Zariviz, C16H16N5NaO7S2, Claforan sodium, MLS000028559, CHEBI:3498, 258J72S7TZ, RU 24756, Sodium 7-(2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido)cephalosporanate, HR-756, SMR000058812, EINECS 264-915-9, MLS002222330, CEFOTAXIME NA-SALT, SMR001307269, CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER, CLAFORAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, Cefotaxim sodium, Claforan (TN), 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, monosodium salt, (6R-(6alpha,7beta(Z)))-, Sodium (6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7(sup 2)-(Z)-(O-methyloxime), acetate (ester), Prestwick_823, Cefotaxime sodium [USAN:USP:JAN], Ru-24756, Cefotaxime, Sodium Salt, Opera_ID_1945, sodium;(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, CHEMBL1010, SCHEMBL41092, Cefotaxime and dextrose 2.4% in plastic container, Cefotaxime and dextrose 3.9% in plastic container, MLS001077352, MLS001333684, Cefotaxime sodium (JP17/USP), HMS1568K20, HMS2095K20, HMS2233J21, HMS3260H18, HMS3712K20, HY-A0088, Sodium (6R-(6alpha,7beta(Z)))-3-(acetoxymethyl)-7-((2-aminothiazol-4-yl)(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, Tox21_500278, 63527-52-6 (acid), s4517, AKOS015951272, CCG-220139, CCG-221582, CS-4297, KS-1416, NCGC00093734-01, NCGC00093734-02, NCGC00260963-01, AN-38760, K035, SMR000653480, AB1009356, EU-0100278, A16005, C 7912, C08113, D00919, J10142, Cefadroxil, Antibiotic for Culture Media Use Only, Q-200807, Cefotaxime sodium salt, potency: 916-964 mug per mg, Cefotaxime sodium, European Pharmacopoeia (EP) Reference Standard, Cefotaxime sodium salt, plant cell culture tested, BioReagent, powder, Cefotaxime sodium, United States Pharmacopeia (USP) Reference Standard, Cefotaxime for peak identification, European Pharmacopoeia (EP) Reference Standard, (6R,7R)-3-[(Acetyloxy)methyl]-7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Sodium Salt, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(acetyloxy)methyl-7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo, monosodium salt, [6R-[6alpha,7 beta (Z)]]-, SODIUM (6R,7R)-3-(ACETOXYMETHYL)-7-((E)-2-(2-AMINOTHIAZOL-4-YL)-2-(METHOXYIMINO)ACETAMIDO)-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE, sodium (6R,7R)-3-(acetoxymethyl)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, sodium (6R,7R)-3-(acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, Sodium (6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 7[2]-(Z)-(O-methyloxime), acetate (ester), sodium 3-(acetoxymethyl)-7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3,4-didehydrocepham-4-carboxylate, cefotaxime, Cefotaximesodium, C16H17N5O7S2.Na, Cefotaxime sodium [USAN:JAN], C16-H16-N5-O7-S2.Na, CID5702018, CID10695961, Cefotaxime sodium salt, 97% - 25G 25g, C2224, CTX, Cefotaxime sodium salt, 92%, a third-generation cephalosporin antibiotic - 25G 25g, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-8-oxo-, monosodium salt, (6R,7R)-, Sodium [6R-[6alpha,7beta(Z)]]-3-(acetoxymethyl)-7-[(2-aminothiazol-4-yl)(methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,

Complexity	839
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	2
Defined Bond Stereocenter Count	1
Exact Mass	477.039g/mol
Formal Charge	0
Heavy Atom Count	31
Hydrogen Bond Acceptor Count	12
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	477.442g/mol
Monoisotopic Mass	477.039g/mol
Rotatable Bond Count	8
Topological Polar Surface Area	230A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H317-H334
Packing Group	Ⅲ
Precautionary statements	P261-P280-P342+P311
UN Code	UN 2811

Certificate of Analysis

Lot Number